Subhash Desai
12Patents
6h-index
16Co-inventors
63Inventor score
Filing activity: Mar 17, 1987 → Sep 23, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4814179A | Floating sustained release therapeutic compositions | Human Necessities | 30 | Expired |
| US4814178A | Floating sustained release therapeutic compositions | Human Necessities | 27 | Expired |
| US6103262A | Modified-release metronidazole compositions and methods for making and using same | Emerging Cross-Sectional Technologies | 12 | Expired |
| US7220434B2 | Dual-release compositions of a cyclooxygenase-2 inhibitor | Human Necessities | 9 | Expired |
| US5609884A | Controlled release naproxen sodium plus naproxen combination tablet | Human Necessities | 8 | Expired |
| US5618559A | Method of making modified-release metronidazole compositions | Emerging Cross-Sectional Technologies | 7 | Expired |
| US9511037B2 | Compositions for reduction of side effects | Human Necessities | 6 | Active |
| US7172769B2 | Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect | Chemistry; Metallurgy | 5 | Expired |
| US5756125A | Controlled release naproxen sodium plus naproxen combination tablet | Human Necessities | 4 | Expired |
| US6030643A | Potassium, sodium and tris oxaprozin salt pharmaceutical formulations | Human Necessities | 4 | Expired |
| US10463633B2 | Therapeutic formulation for reduced drug side effects | Emerging Cross-Sectional Technologies | 0 | Active |
| US10912744B2 | Therapeutic formulation for reduced drug side effects | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.